Breaking newsCOVID-19 Early Convalescent Plasma for High-Risk Outpatients with COVID-19 September 6, 2021 In this trial, the authors assigned COVID-19 patients to receive either one unit of convalescent plasma with a high titer of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a placebo.
